Christina Kopp

651 total citations
12 papers, 368 citations indexed

About

Christina Kopp is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Gastroenterology. According to data from OpenAlex, Christina Kopp has authored 12 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 4 papers in Gastroenterology. Recurrent topics in Christina Kopp's work include Gastric Cancer Management and Outcomes (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Christina Kopp is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Christina Kopp collaborates with scholars based in Germany, Switzerland and Italy. Christina Kopp's co-authors include M. Mielenz, H. Sauerwein, S. P. Singh, Petra Regenhard, Ute Müller, Susanne Häußler, Clarissa Ganda, Patrick A. Candy, Jacob George and Tasnuva D. Kabir and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Christina Kopp

12 papers receiving 360 citations

Peers

Christina Kopp

PRM

SURGE

ONCOL

Heather Mangian United States

Mi-Young Kim South Korea

Aktham Hassan France

Khaly Mbodji Canada

Takashi Akutagawa Japan

Hongyan Chen China

Yingtong Feng China

Deniz Tümen Germany

Tony Y. Wang United States

J. Mørkholdt Andersen Denmark

Heather Mangian United States

Christina Kopp

188 ×1.8

44 ×0.5

PRM

43 ×0.5

SURGE

97 ×1.3

66 ×1.0

ONCOL

Citations per year, relative to Christina Kopp Christina Kopp (= 1×) peers Heather Mangian

Countries citing papers authored by Christina Kopp

Since Specialization

Citations

This map shows the geographic impact of Christina Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Kopp more than expected).

Fields of papers citing papers by Christina Kopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Kopp. The network helps show where Christina Kopp may publish in the future.

Co-authorship network of co-authors of Christina Kopp

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Kopp. A scholar is included among the top collaborators of Christina Kopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Kopp. Christina Kopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kopp, Christina, et al.. (2025). Postprandial Responses to Meals Enriched With Canola or Coconut Oil in Men and Women With a Risk Phenotype for Cardiometabolic Diseases: A Randomized Crossover Trial. Molecular Nutrition & Food Research. 69(19). e70147–e70147. 1 indexed citations

Al‐Batran, Salah‐Eddin, Sylvie Lorenzen, Stefan Angermeier, et al.. (2024). A randomized, open-label phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophagogastric junction and high immune responsiveness: The IKF633/DANTE trial, a trial of AIO in collaboration with SAKK.. Journal of Clinical Oncology. 42(16_suppl). TPS4184–TPS4184. 1 indexed citations

Al-Batran, Salah-Eddin, Sylvie Lorenzen, Peter Thuss‐Patience, et al.. (2023). A randomized, open-label, phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophagogastric junction and high immune responsiveness: The IKF-S633/DANTE trial, a trial of AIO in collaboration with SAKK.. Journal of Clinical Oncology. 41(16_suppl). TPS4177–TPS4177. 5 indexed citations

Al-Batran, Salah-Eddin, Sylvie Lorenzen, Peter Thuss‐Patience, et al.. (2022). Surgical and pathological outcome, and pathological regression, in patients receiving perioperative atezolizumab in combination with FLOT chemotherapy versus FLOT alone for resectable esophagogastric adenocarcinoma: Interim results from DANTE, a randomized, multicenter, phase IIb trial of the FLOT-AIO German Gastric Cancer Group and Swiss SAKK.. Journal of Clinical Oncology. 40(16_suppl). 4003–4003. 70 indexed citations

Al-Batran, S-E., Sylvie Lorenzen, Nils Homann, et al.. (2021). 1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK. Annals of Oncology. 32. S1069–S1069. 22 indexed citations

Kopp, Christina, Sylvie Lorenzen, Timo Gaiser, et al.. (2021). 1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK. Annals of Oncology. 32. S1069–S1070. 2 indexed citations

Kabir, Tasnuva D., Clarissa Ganda, Rikki A. M. Brown, et al.. (2017). A microRNA‐7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib‐resistant cells in human hepatocellular carcinoma. Hepatology. 67(1). 216–231. 107 indexed citations

Kopp, Christina, S. P. Singh, Petra Regenhard, et al.. (2014). Trans-Cinnamic Acid Increases Adiponectin and the Phosphorylation of AMP-Activated Protein Kinase through G-Protein-Coupled Receptor Signaling in 3T3-L1 Adipocytes. International Journal of Molecular Sciences. 15(2). 2906–2915. 47 indexed citations

Kopp, Christina, Afshin Hosseini, S. P. Singh, et al.. (2014). Nicotinic Acid Increases Adiponectin Secretion from Differentiated Bovine Preadipocytes through G-Protein Coupled Receptor Signaling. International Journal of Molecular Sciences. 15(11). 21401–21418. 33 indexed citations

10.

Saremi, B., M. Mielenz, Afshin Hosseini, et al.. (2013). Hepatic and extrahepatic expression of serum amyloid A3 during lactation in dairy cows. Journal of Dairy Science. 96(11). 6944–6954. 10 indexed citations

11.

Mielenz, M., et al.. (2012). Development, validation, and pilot application of a semiquantitative Western blot analysis and an ELISA for bovine adiponectin. Domestic Animal Endocrinology. 44(3). 121–130. 58 indexed citations

12.

Chapusot, Caroline, Laurent Martin, David Rageot, et al.. (2003). Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas. Histopathology. 43(1). 40–47. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact